The estimated effectiveness of the monoclonal antibody drug nirsevimab was 89% against medically attended respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback